Veeva Systems (BSP:V2EE34) ROCE %: 14.37% (As of Apr. 2026)


BSP:V2EE34 Veeva Systems Inc BSP:V2EE34
93 GF Score
Price R$29.15
GF Value R$48.51
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Veeva Systems ROCE %?

Veeva Systems BSP:V2EE34 +7.25% 93 ROCE % is 14.37% as of Apr. 2026. GuruFocus rates BSP:V2EE34 with a GF Score™ of 93/100 and a GF Value™ of R$48.51 (Significantly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Veeva Systems's annualized ROCE % for the quarter that ended in Apr. 2026 was 14.37%.

Veeva Systems  (BSP:V2EE34) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Veeva Systems ROCE % Related Terms

Veeva Systems ROCE % Historical Data

* Premium members only.

The historical data trend for Veeva Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veeva Systems ROCE % Chart

Veeva Systems Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.30 13.18 9.82 14.09 13.05

Veeva Systems Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.99 11.74 13.68 13.51 14.37
BSP:V2EE34
93GF Score
Veeva Systems Inc BSP:V2EE34
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veeva Systems ROCE % Calculation

Veeva Systems's annualized ROCE % for the fiscal year that ended in Jan. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=4885.713/( ( (44118.539 - 8405.667) + (47874.265 - 8728.128) )/ 2 )
=4885.713/( (35712.872+39146.137)/ 2 )
=4885.713/37429.5045
=13.05 %

Veeva Systems's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=5499.272/( ( (47874.265 - 8728.128) + (45957.282 - 8566.54) )/ 2 )
=5499.272/( ( 39146.137 + 37390.742 )/ 2 )
=5499.272/38268.4395
=14.37 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.37% mean?
Veeva Systems (BSP:V2EE34) has a ROCE % of 14.37% as of Apr. 2026.
Is Veeva Systems' ROCE % too high?
Veeva Systems' current ROCE % is 14.37%. The Healthcare Providers & Services industry median ROCE % is 6.41. Veeva Systems' value of 14.37% is 124.2% above this industry median. Overall, Veeva Systems has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' ROCE % compare to BTSG and TEM?
Veeva Systems' ROCE % of 14.37% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Veeva Systems' value of 14.37% is 124.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current ROCE % of 14.37% is 124.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current ROCE % is 14.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$48.51, compared to a current price of R$29.15 — trading 39.9% below its estimated fair value. The current ROCE % is 14.37% and 124.2% above the Healthcare Providers & Services industry median of 6.41. Veeva Systems' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current ROCE % is 14.37% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?

Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued. The current stock price of R$29.15 is trading 39.9% below its estimated GF Value™ of R$48.51. GuruFocus considers Veeva Systems to be Significantly Undervalued.

Key valuation signals for BSP:V2EE34:

  • ROCE %: 14.37%
  • GF Value™: R$48.51 vs. price of R$29.15 (39.9% below fair value)
  • GF Score™: 93/100 with 1 warning sign
  • Industry Position: 124.2% above the Healthcare Providers & Services median

No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Veeva Systems Business Description

Address 4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
93GF Score

Get the complete analysis for BSP:V2EE34

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$29.15
Price
R$48.51
GF Value